Increased competition from regions with more streamlined regulatory environments, such as China: China's favorable regulatory environment, including factors such as the National Reimbursement Drug List (NRDL) expansion, a large pool of treatment-nave patients, and an increase in China-headquartered companies sponsoring trials have attracted a significant portion of clinical trials, particularly Phase 1 and CGTs 2
Neurochemistry of major depression: a study using magnetic resonance spectroscopy
Professional Care : Your safety and comfort are our priorities, and we ensure all treatments are administered in a secure and welcoming environment
symptoms recurred in some patients when the same or another DPP-4 inhibitor was restarted
Acarbose oral tablet can interact with other medications, herbs, or vitamins you might be taking
Diagnostic and Statistical Manual of Mental Disorders (DSM-5)